EUVIMEDEUVIMED entdecken
Crossref

Governing aging rate indicators from clinical trials to clinical use

Frontiers Policy Labs

Frontiers · 16.09.2026

DOI: 10.25453/plabs.33854755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers, erschienen am 16.09.2026. Verfasst von Frontiers Policy Labs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dr Michael S. Ringel, Life Biosciences, USA; Dr Carolyn B. Ringel, Harvard Medical School, USA — Biomarkers of aging can inform drug trials and clinical decisions as supportive evidence while formal validation continues. For a full article, please click here.

Schlagwörter

aging biomarkersclinical trialsclinical translationdrug developmentbiomarker validation

Zitieren

APA

Labs, F. P. (2026). Governing aging rate indicators from clinical trials to clinical use. Frontiers. https://doi.org/10.25453/plabs.33854755

Vancouver

Labs FP. Governing aging rate indicators from clinical trials to clinical use. Frontiers. 2026. doi:10.25453/plabs.33854755

BibTeX
@article{Labs2026,
  author = {Labs, Frontiers Policy},
  title = {Governing aging rate indicators from clinical trials to clinical use},
  journal = {Frontiers},
  year = {2026},
  doi = {10.25453/plabs.33854755}
}
Kostenlos starten →